» Articles » PMID: 33117462

Clinicopathologic Features and Survival Trends for Acinic Cell Carcinoma of the Major Salivary Glands: A Surveillance, Epidemiology, and End Results Population Analysis

Overview
Journal World J Oncol
Specialty Oncology
Date 2020 Oct 29
PMID 33117462
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We analyzed a population-based national registry to identify the most influential patient pretreatment and treatment factors affecting overall survival (OS) and cause-specific survival (CSS) in patients diagnosed with acinic cell carcinoma (ACC) of the major salivary glands.

Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database of the US National Cancer Institute (NCI) related to survival, a total of 1,254 patients with diagnosed ACC of the major salivary glands from 1975 to 2016 met inclusion criteria. Factors significant for OS and CSS were determined using univariate and multivariate analysis with the Cox proportional hazards model.

Results: Univariate OS analysis demonstrated that surgery favorably influenced longer survival compared to no surgery (hazard ratio (HR) 2.35, P < 0.05). Patient age was found to be highly predictive of superior OS (divided into 10-year age bands, P < 0.0001, younger age better). In multivariate OS analysis, there were statistically significant worse outcomes for men (HR 1.54, P < 0.05), grades III/IV (HR 2.5, P < 0.05), and distant disease (HR 3.55, P < 0.05) or regional disease (HR 1.22, P < 0.05). Patients diagnosed during years 1996 - 2016 had better OS when compared to earlier decades 1975 - 1995 (HR 1.38, P < 0.05). In univariate analysis, the mean CSS for grades I, II, and III/IV were 429 months (95% confidence interval (CI), ± 38.39), 426 months (95% CI, ± 25.73) and 198 months (95% CI, ± 66.38). Multivariate analysis of CSS further demonstrated that there were statistically significant worse outcomes for men (HR 1.68, P < 0.05), grade III/IV (HR 3.2, P < 0.05), tumor size greater than 40 mm (P < 0.001), and distant disease (HR 4.48, P < 0.05) or regional disease (HR 1.84, P < 0.05).

Conclusions: To our knowledge, this is the largest population-based study of OS and CSS of major salivary gland ACC. We found that the patient pretreatment and treatment factors including younger age at diagnosis, female sex, early stage, lower grade, surgical excision, and recent year of diagnosis are associated with improved survival in patients diagnosed with ACC of the major salivary glands. We hope that this information will aid in construction of further research projects that better refine optimal treatment protocol of individualized patient care.

Citing Articles

Prognostic factors for sublingual gland carcinoma: a population-based Surveillance, Epidemiology and End Results database study.

Qin G, Wu L, Li C, Zhang Q, An Z, Qin J J Int Med Res. 2023; 51(11):3000605231187940.

PMID: 37944187 PMC: 10637180. DOI: 10.1177/03000605231187940.


Acinic Cell Carcinoma in the 21st Century: A Population-Based Study from the SEER Database and Review of Recent Molecular Genetic Advances.

Khan J, Ullah A, Goodbee M, Lee K, Yasinzai A, Lewis Jr J Cancers (Basel). 2023; 15(13).

PMID: 37444484 PMC: 10340722. DOI: 10.3390/cancers15133373.

References
1.
Sood A, Houlton J, Nguyen S, Gillespie M . Facial nerve monitoring during parotidectomy: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2015; 152(4):631-7. DOI: 10.1177/0194599814568779. View

2.
Laramore G . Fast neutron radiotherapy for inoperable salivary gland tumors: is it the treatment of choice?. Int J Radiat Oncol Biol Phys. 1987; 13(9):1421-3. DOI: 10.1016/0360-3016(87)90240-9. View

3.
Zbaren P, Schreiber B, Lehmann W, Widgren S . [Acinar cell carcinoma of the salivary glands]. Laryngol Rhinol Otol (Stuttg). 1987; 66(6):320-3. View

4.
Hoffman H, Karnell L, Robinson R, Pinkston J, Menck H . National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck. 1999; 21(4):297-309. DOI: 10.1002/(sici)1097-0347(199907)21:4<297::aid-hed2>3.0.co;2-r. View

5.
Ferrell J, Mace J, Clayburgh D . Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review. Eur Arch Otorhinolaryngol. 2019; 276(4):1135-1146. DOI: 10.1007/s00405-019-05282-2. View